摘要
目的 为腹膜透析液的配送上门服务及药学服务提供思路。方法 设计调查问卷,采取现场调研或电话回访的方式对医院2021年6月至2023年12月选择腹膜透析液配送上门的152例患者进行回访,对腹膜透析液配送上门服务的满意度、患者居家腹膜透析期间药品管理情况、药品不良反应(ADR)发生情况、用药教育情况进行调研。结果 152例受访患者中,腹膜透析时长为6个月以内的29例(19.08%),6个月至2年的61例(40.13%),2年以上的62例(40.79%)。147例(96.71%)对腹膜透析液配送上门服务的满意度评分为10分。122例(80.26%)规范储存腹膜透析液;102例(67.11%)能规范、正确操作腹膜透析液;114例(75.00%)知晓腹膜透析液的加药顺序且能正确操作。92例(60.53%)在居家腹膜透析期间发生过ADR,发生频次最高的为溶剂相关ADR(46.05%)。ADR处理办法主要咨询医师(96.71%)和护士(49.34%);134例(88.16%)知晓全部用药注意事项;145例(95.39%)有药学服务需求,其中需求率最高的为ADR处理办法(70.39%)。非参数秩和检验结果显示,透析时长超过6个月患者的ADR发生率显著高于6个月以内的患者(χ^(2)=22.494,P <0.001)。结论 患者对腹膜透析液配送上门服务的满意度较高,部分患者对腹膜透析液的使用、储存不规范,大部分患者居家腹膜透析期间发生过ADR。腹膜透析患者对药学服务有较高需求,药师可开展ADR处理、提高用药依从性等居家药学服务,促进安全、合理用药。
Objective To provide ideas for door-to-door delivery of peritoneal dialysate and pharmaceutical care.MethodsA survey questionnaire was designed to conduct on-site survey or telephone follow-up on 152 patients who chose to door-to-door delivery of peritoneal dialysate from June 2021 to December 2023 in the hospital.The satisfaction with the door-to-door delivery service of peritoneal dialysate,the situation of drug management during home peritoneal dialysis,occurrence of adverse drug reactions(ADRs),and medication education were surveyed.Results Among the 152 surveyed patients,29 cases(19.08%) had peritoneal dialysis duration within six months,61 cases(40.13%) had peritoneal dialysis duration between six months and two years,and 62 cases(40.79%) had peritoneal dialysis duration over two years.A total of147 cases(96.71%) had a satisfaction score of 10 points for the door-to-door delivery service of peritoneal dialysate.A total of 122 cases(80.26%) were able to store peritoneal dialysate in a standardized manner;a total of 102 cases(67.11%)were able to operate peritoneal dialysate in a standardized and correct manner;a total of 114 cases(75.00%) knew the dosing sequence of peritoneal dialysate and were able to operate it correctly.A total of 92 cases(60.53%) had ADR during home peritoneal dialysis,with the highest incidence rate being solvent-related ADR(46.05%),and the main methods for handling ADR were to consult with physicians(96.71%) and nurses(49.34%);a total of 134 cases(88.16%) knew all medication precautions;a total of 145 patients(95.39%) had a demand for pharmaceutical care,with the highest demand rate being ADR treatment methods(70.39%).The non-parametric rank sum test results showed that the incidence of ADR in patients with dialysis duration over six months was significantly higher than that in patients with dialysis duration within six months (χ^(2)=22.494,P < 0.001).Conclusion The patients had a high satisfaction with the door-to-door delivery service of peritoneal dialysate,some patients have non-s
作者
陈和莉
何蓉
枉前
CHEN Heli;HE Rong;WANG Qian(The First Affiliated Hospital of Army Medical University,Chongqing,China 400038)
出处
《中国药业》
CAS
2024年第15期21-24,共4页
China Pharmaceuticals
基金
重庆市临床药学重点专科建设项目[渝卫办发[2021]52号]。
关键词
腹膜透析液
配送上门
居家药学服务
peritoneal dialysate
door-to-door delivery
home pharmaceutical care
